Northwestern Mutual Wealth Management CO Regeneron Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

$112 Billion
Q3 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 3,969 shares of REGN stock, worth $2.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,969

Previous 3,821 3.87%

Holding current value

$2.79 Million

Previous $4.02 Million 3.91%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $151,565 - $177,860	148 Added 3.87%	3,969 $4.17 Million
Q2 2024 Aug 15, 2024	BUY	$883.2 - $1071.19 $473,395 - $574,157	536 Added 16.32%	3,821 $4.02 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $424,264 - $466,874	-470 Reduced 12.52%	3,285 $3.16 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $66,665 - $75,826	86 Added 2.34%	3,755 $3.3 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $33,930 - $41,374	49 Added 1.35%	3,669 $3.02 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $4,200 - $4,982	-6 Reduced 0.17%	3,620 $2.6 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $163,998 - $199,299	-241 Reduced 6.23%	3,626 $2.98 Million
Q4 2022 Feb 21, 2023	BUY	$705.89 - $766.39 $132,707 - $144,081	188 Added 5.11%	3,867 $2.79 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $115,367 - $145,588	-201 Reduced 5.18%	3,679 $2.54 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $382,748 - $515,710	698 Added 21.94%	3,880 $2.29 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $287,442 - $337,341	-483 Reduced 13.18%	3,182 $2.22 Million
Q4 2021 Feb 03, 2022	SELL	$543.48 - $670.97 $90,761 - $112,051	-167 Reduced 4.36%	3,665 $2.32 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $384,026 - $455,562	669 Added 21.15%	3,832 $2.32 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $133,802 - $158,066	283 Added 9.83%	3,163 $1.77 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $160,822 - $197,352	360 Added 14.29%	2,880 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $9,087 - $11,551	-19 Reduced 0.75%	2,520 $1.22 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $99,144 - $119,794	182 Added 7.72%	2,539 $1.42 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $101,130 - $132,003	205 Added 9.53%	2,357 $1.47 Million
Q1 2020 May 08, 2020	SELL	$336.18 - $494.43 $229,274 - $337,201	-682 Reduced 24.06%	2,152 $1.05 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $69,903 - $96,010	255 Added 9.89%	2,834 $1.06 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $212,751 - $247,707	778 Added 43.2%	2,579 $715,000
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $39,547 - $54,756	132 Added 7.91%	1,801 $564,000
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $6,697 - $7,912	18 Added 1.09%	1,669 $685,000
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $67,835 - $81,414	202 Added 13.94%	1,651 $617,000
Q3 2018 Nov 01, 2018	SELL	$351.14 - $408.51 $44,243 - $51,472	-126 Reduced 8.0%	1,449 $586,000
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $9,676 - $11,729	-34 Reduced 2.11%	1,575 $543,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $57,479 - $71,667	-182 Reduced 10.16%	1,609 $554,000
Q4 2017 Jan 31, 2018	BUY	$358.63 - $469.95 $14,345 - $18,798	40 Added 2.28%	1,791 $673,000
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $29,765 - $34,776	69 Added 4.1%	1,751 $783,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,682	1,682 $825,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Regeneron Pharmaceuticals, Inc. Transaction History